Law360, New York (September 28, 2009) -- Johnson & Johnson subsidiary Cordis Corp. has appealed a $22 million verdict for Spectralytics Inc. in a patent infringement dispute between the medical device makers over a stent-cutting machine, on the heels of Cordis' victory in another stent patent suit.
Cordis and its co-defendant, stent manufacturer Norman Noble Inc., filed notice of their appeal to the U.S. Court of Appeals for the Federal Circuit in the U.S. District Court for...
